Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IV Clinical Trial to Evaluate Efficacy and Safety of Qsymia in Obese Patients

NCT05378503 is registered in ClinicalTrials.gov with Alvogen Korea as lead sponsor.

NCT NCT05378503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IV Clinical Trial to Evaluate Efficacy and Safety of Qsymia in Obese Patients
Lead sponsor
Alvogen Korea
Phase
Phase 4
Overall status
Completed
Start date
September 17, 2021
Completion date
October 30, 2023
Enrollment
232 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

obesity